PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Providers & Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Education
    • Research Updates
      • Daily Psych Blog
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
Ketamine in OCD: New Potential, New Risks
DisordersKetamineMedicationsOCDResearch

Ketamine in OCD: New Potential, New Risks

August 27, 2026by Chris Aiken, MD0
How Ketamine Quiets Rumination
DepressionKetamineMedicationsResearchResearch for the Public

How Ketamine Quiets Rumination

August 21, 2026by Chris Aiken, MD0
Esketamine in Teens: A Randomized Trial
Child PsychiatryDepressionDifficult to Treat DepressionDisordersKetamineMedicationsResearchTop Research

Esketamine in Teens: A Randomized Trial

August 3, 2026by Chris Aiken, MD0
Ketamine for Addiction
Addiction MedsAlcoholCocaineDisordersKetamineMedicationsOpioidsResearchSubstance Use

Ketamine for Addiction

July 24, 2026by Chris Aiken, MD0
Ketamine and Cognition, A Randomized Trial
CognitionDepressionDifficult to Treat DepressionKetamineMedicationsResearch

Ketamine and Cognition, A Randomized Trial

July 10, 2026by Chris Aiken, MD0
Oral Ketamine Delivers Mixed Signals
DepressionDifficult to Treat DepressionDisordersKetamineMedicationsResearch

Oral Ketamine Delivers Mixed Signals

June 26, 2026by Chris Aiken, MD0
Ketamine in Teens with Suicidality
Child PsychiatryDepressionDifficult to Treat DepressionKetamineResearch

Ketamine in Teens with Suicidality

June 8, 2026by Chris Aiken, MD0
Psychotherapy Makes a Difference with Esketamine
DepressionDifficult to Treat DepressionKetamineMedicationsResearchTherapy

Psychotherapy Makes a Difference with Esketamine

May 22, 2026by Chris Aiken, MD0
A Drug That Sustains Ketamine’s Benefits
DepressionDifficult to Treat DepressionKetamineResearchTop Research

A Drug That Sustains Ketamine’s Benefits

May 20, 2026by Chris Aiken, MD0
New Trials Look Long-Term in Treatment-Resistant Depression
AntidepressantsDepressionDifficult to Treat DepressionKetamineLithiumMedications

New Trials Look Long-Term in Treatment-Resistant Depression

May 20, 2026by Chris Aiken, MD0
Who Responds to Ketamine?
AntidepressantsBipolarDepressionDifficult to Treat DepressionKetamineMedicationsPersonality DisordersResearch

Who Responds to Ketamine?

May 18, 2026by Chris Aiken, MD0
CBT Helps Sustain Esketamine
DepressionDifficult to Treat DepressionKetamineResearchTherapyTop Research

CBT Helps Sustain Esketamine

May 7, 2026by Chris Aiken, MD0
Esketamine Over Five Years: Real World Data
DepressionDifficult to Treat DepressionKetamineMedicationsResearch

Esketamine Over Five Years: Real World Data

May 3, 2026by Chris Aiken, MD0
Ketamine and Liver Risk: How Worried Should You Be?
DepressionDifficult to Treat DepressionKetamineMedicationsSide EffectsTop Research

Ketamine and Liver Risk: How Worried Should You Be?

April 22, 2026by Chris Aiken, MD0
Benzodiazepines May Blunt Esketamine
BenzodiazepinesDepressionDifficult to Treat DepressionKetamineMedicationsResearch

Benzodiazepines May Blunt Esketamine

April 6, 2026by Chris Aiken, MD1
Top Studies
All Studies
Self Help
Become a Therapy Partner

Recent Posts

  • August 27, 2026Remembering Jules Angst, Bipolar Pioneer

  • August 27, 2026Naltrexone vs Buprenorphine for Opioid Use Disorder

  • August 27, 2026Ketamine in OCD: New Potential, New Risks

  • August 26, 2026Close Quarters in Antarctica: Paranoia and Loneliness

  • August 26, 2026Dark Chocolate for Cognition

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Sexual dysfunction
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image